Please login to the form below

Not currently logged in

Alzheimer's Research UK

This page shows the latest Alzheimer's Research UK news and features for those working in and with pharma, biotech and healthcare.

Biogen’s highly-anticipated Alzheimers drug wins FDA fast-track

Biogen’s highly-anticipated Alzheimer’s drug wins FDA fast-track

If approved, aducanumab will become the first treatment to reduce the clinical decline of Alzheimer’s disease, which affects around six in every ten people with dementia in the UK, according ... to Alzheimer’s Research UK.

Latest news

More from news
Approximately 3 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • Detecting Alzheimer’s ahead of a cure Detecting Alzheimers ahead of a cure

    Alzheimer’s Research UK is launching head first into the fight, with a new drive towards therapies that avoid the Abeta route. ... A new company has been created from Alzheimer’s Research UK’s Drug Discovery Alliance, which will build on the work

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimers drug discovery

    Led by the British dementia research charity, Alzheimer’s Research UK, it aims to bring together academic researchers with pharma and biotech to accelerate the development of novel treatments. ... Dr Carol Routledge, Director of Research at

  • Holding on to hope for Alzheimer’s advances Holding on to hope for Alzheimers advances

    Funds need to keep flowing. There are fears that the constant failures in the clinic are going to lead to a drop in investment for Alzheimer’s research. ... The project is a joint £250m investment into dementia research led by the Medical Research

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Metrion Biosciences establishes scientific advisory board Metrion Biosciences establishes scientific advisory board

    Contract research organisation and drug discovery business Metrion Biosciences has established a scientific advisory board, which will provide strategic scientific guidance to the company. ... The new board will be chaired by Dr Keith McCullagh,

  • UK Dementia Research Institute names director UK Dementia Research Institute names director

    In his new role, Prof De Strooper will work with the institute's founding partners - the Medical Research Council, Alzheimer's Society and Alzheimer's Research UK - to develop new therapeutics ... The UK research landscape is brimming with talent and

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Mednet Group Mednet Group

    Roadshows. Medical Strategy &Writing. Market Research. Digital Behaviour &User Research. Strategic Planning. ... Alzheimer’s Research UK. Alzheimer’s Society. Basic Needs. Biogen. Butterfly Scheme. Cardiomyopathy UK.

  • Forecasting in Forgotten Markets

    Though vastly different topics, both meetings included presentations on new approaches to help kick start research in markets. . ... This charitable fund represents collaboration between the Department of Health, Alzheimer’s Research UK () and a

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

up to your ears in it? some pressure is helpful but too much of the wrong sort quickly takes its...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....